Your browser doesn't support javascript.
loading
Monitoring PD-1 Phosphorylation to Evaluate PD-1 Signaling during Antitumor Immune Responses.
Bu, Xia; Juneja, Vikram R; Reynolds, Carol G; Mahoney, Kathleen M; Bu, Melissa T; McGuire, Kathleen A; Maleri, Seth; Hua, Ping; Zhu, Baogong; Klein, Sarah R; Greenfield, Edward A; Armand, Philippe; Ritz, Jerome; Sharpe, Arlene H; Freeman, Gordon J.
Afiliação
  • Bu X; Department of Medical Oncology, Dana-Farber Cancer Institute, and Department of Medicine, Harvard Medical School, Boston, Massachusetts.
  • Juneja VR; Harvard-MIT Division of Health Sciences and Technology, Cambridge, Massachusetts.
  • Reynolds CG; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, Massachusetts.
  • Mahoney KM; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts.
  • Bu MT; Department of Medical Oncology, Dana-Farber Cancer Institute, and Department of Medicine, Harvard Medical School, Boston, Massachusetts.
  • McGuire KA; Department of Medical Oncology, Dana-Farber Cancer Institute, and Department of Medicine, Harvard Medical School, Boston, Massachusetts.
  • Maleri S; Department of Medical Oncology, Dana-Farber Cancer Institute, and Department of Medicine, Harvard Medical School, Boston, Massachusetts.
  • Hua P; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, Massachusetts.
  • Zhu B; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts.
  • Klein SR; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, Massachusetts.
  • Greenfield EA; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts.
  • Armand P; Department of Medical Oncology, Dana-Farber Cancer Institute, and Department of Medicine, Harvard Medical School, Boston, Massachusetts.
  • Ritz J; Department of Medical Oncology, Dana-Farber Cancer Institute, and Department of Medicine, Harvard Medical School, Boston, Massachusetts.
  • Sharpe AH; Department of Medical Oncology, Dana-Farber Cancer Institute, and Department of Medicine, Harvard Medical School, Boston, Massachusetts.
  • Freeman GJ; Department of Medical Oncology, Dana-Farber Cancer Institute, and Department of Medicine, Harvard Medical School, Boston, Massachusetts.
Cancer Immunol Res ; 9(12): 1465-1475, 2021 12.
Article em En | MEDLINE | ID: mdl-34635486
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptor de Morte Celular Programada 1 / Imunidade / Imunoterapia / Anticorpos Monoclonais Limite: Animals / Humans Idioma: En Revista: Cancer Immunol Res Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptor de Morte Celular Programada 1 / Imunidade / Imunoterapia / Anticorpos Monoclonais Limite: Animals / Humans Idioma: En Revista: Cancer Immunol Res Ano de publicação: 2021 Tipo de documento: Article